CWA Asset Management Group LLC Invests $382,000 in iShares Biotechnology ETF (NASDAQ:IBB)

CWA Asset Management Group LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,890 shares of the financial services provider’s stock, valued at approximately $382,000.

Other hedge funds have also recently added to or reduced their stakes in the company. National Bank of Canada FI increased its stake in shares of iShares Biotechnology ETF by 9.1% in the 2nd quarter. National Bank of Canada FI now owns 3,895 shares of the financial services provider’s stock valued at $533,000 after acquiring an additional 324 shares during the last quarter. Choreo LLC increased its stake in iShares Biotechnology ETF by 54.9% in the second quarter. Choreo LLC now owns 3,465 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 1,228 shares in the last quarter. Blue Square Asset Management LLC raised its holdings in iShares Biotechnology ETF by 20.5% in the second quarter. Blue Square Asset Management LLC now owns 19,322 shares of the financial services provider’s stock worth $2,652,000 after purchasing an additional 3,284 shares during the period. Garrison Point Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 1.5% during the second quarter. Garrison Point Advisors LLC now owns 10,442 shares of the financial services provider’s stock worth $1,433,000 after purchasing an additional 158 shares in the last quarter. Finally, Eagle Strategies LLC grew its holdings in shares of iShares Biotechnology ETF by 551.8% in the 2nd quarter. Eagle Strategies LLC now owns 11,674 shares of the financial services provider’s stock valued at $1,602,000 after buying an additional 9,883 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.5 %

Shares of iShares Biotechnology ETF stock opened at $134.83 on Thursday. The stock’s fifty day simple moving average is $138.26 and its 200 day simple moving average is $142.05. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.